Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$14.00 – $18.38
42% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $124.12B | $121.39B | $136.97B | $130.87B | $134.91B | $136.73B | $164.00B | $148.63B |
| Cost of revenue | $56.21B | $58.60B | $62.04B | $64.93B | $70.83B | $75.74B | $71.35B | $68.77B |
| Gross profit | $67.91B | $62.78B | $74.93B | $65.94B | $64.09B | $60.99B | $92.64B | $79.86B |
| Gross margin | 54.7% | 51.7% | 54.7% | 50.4% | 47.5% | 44.6% | 56.5% | 53.7% |
| R&D | $1.18B | $775.0M | $167.0M | $64.0M | $806.0M | $770.0M | $0 | $0 |
| Operating income | $13.51B | −$45.68B | $22.50B | $11.46B | $4.20B | −$28.27B | $28.97B | $27.84B |
| EBITDA | $29.62B | −$28.13B | $38.10B | $17.77B | $10.37B | −$20.77B | $38.15B | $34.91B |
| Net income | $12.71B | −$49.17B | $25.63B | $30.53B | $8.86B | −$28.68B | $24.19B | $19.17B |
| Net margin | 10.2% | -40.5% | 18.7% | 23.3% | 6.6% | -21.0% | 14.8% | 12.9% |
| EPS (diluted) | 87.35 | -352.49 | 207.24 | 256.20 | 76.70 | -257.60 | 216.92 | 172.56 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $145.0B | $167.18 | $159.72–$184.66 | 1 |
| 2028 | $146.9B | $167.04 | $159.60–$184.51 | 1 |
| 2029 | $149.9B | $159.23 | $152.13–$175.88 | 1 |
| 2030 | $148.3B | $177.03 | $169.14–$195.54 | 1 |
Forward consensus · source: Financial Modeling Prep
DENA CO LTD ORD
No one on the platform currently holds DNACF.
No tracked institution reports a position in DNACF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-03-31 | $66.0000 | 2026-06-29 |
| 2025-03-31 | $33.0000 | 2025-06-23 |
| 2025-03-31 | $32.0000 | 2025-06-23 |
| 2024-03-28 | $20.0000 | 2024-06-24 |
| Execution date | Ratio |
|---|---|
| 2010-05-27 | 300-for-1 |
| 2005-09-27 | 3-for-1 |
No one on the platform has traded DNACF yet.
| $2.0B |
| — |
| MIXIFmixi, Inc. | $26.18 | +23.03% | $1.7B | — |
| PRXXFParadox Interactive AB (publ) | $12.89 | +0.00% | $1.4B | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 0.1× earnings vs its 0.1× historical median P/E.
Fair value ≈ $20.64 · price $15.85 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.